Allmed Medical Products Co.,Ltd - Laporan Laba Rugi (TTM)

Allmed Medical Products Co.,Ltd
CN ˙ SZSE
CN¥ 10.04 ↑0.16 (1.62%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Allmed Medical Products Co.,Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 3,730 3,834 4,058 3,076 3,073 2,926 3,098 3,563 3,665 4,211 4,032 3,503 3,162 2,757 2,688 2,912 3,188 3,326 3,339 3,421
Change (%) 2.81 5.82 -24.20 -0.08 -4.80 5.89 15.02 2.86 14.87 -4.24 -13.13 -9.74 -12.81 -2.48 8.30 9.51 4.32 0.37 2.47
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,173 2,224 2,406 1,976 2,155 2,053 2,164 2,401 2,412 2,812 2,677 2,416 2,202 2,099 2,088 2,228 2,446 2,398 2,394 2,450
Change (%) 2.36 8.19 -17.87 9.05 -4.72 5.39 10.97 0.46 16.56 -4.79 -9.75 -8.87 -4.68 -0.50 6.71 9.75 -1.94 -0.18 2.35
% of Revenue 58.26 58.00 59.30 64.26 70.13 70.19 69.85 67.39 65.81 66.78 66.40 68.98 69.64 76.13 77.68 76.54 76.70 72.10 71.70 71.62
Gross Operating Profit 1,557 1,610 1,651 1,099 918 872 934 1,162 1,253 1,399 1,355 1,087 960 658 600 683 743 928 945 971
Change (%) 3.45 2.54 -33.43 -16.50 -4.98 7.09 24.41 7.84 11.61 -3.12 -19.80 -11.67 -31.46 -8.78 13.83 8.74 24.93 1.80 2.77
% of Revenue 41.74 42.00 40.70 35.74 29.87 29.81 30.15 32.61 34.19 33.22 33.60 31.02 30.36 23.87 22.32 23.46 23.30 27.90 28.30 28.38
SG&A 387 288 294 282 268 371 404 454 482 448 440 385 362 386 356 370 376 378 392 377
Change (%) -25.62 2.05 -4.14 -4.88 38.38 9.01 12.38 6.13 -7.03 -1.93 -12.35 -6.05 6.66 -7.82 3.89 1.82 0.29 3.76 -3.69
% of Revenue 10.38 7.51 7.24 9.16 8.72 12.68 13.05 12.75 13.15 10.65 10.90 11.00 11.45 14.01 13.24 12.70 11.81 11.35 11.73 11.03
R&D 64 118 139 129 127 95 81 86 82 108 112 114 122 77 74 78 75 106 118 126
Change (%) 84.33 17.88 -7.54 -1.43 -25.48 -14.32 6.32 -4.69 31.20 4.22 1.90 6.77 -36.67 -4.35 5.59 -3.81 41.53 10.68 7.36
% of Revenue 1.72 3.08 3.43 4.19 4.13 3.23 2.62 2.42 2.24 2.56 2.78 3.27 3.86 2.81 2.75 2.68 2.36 3.20 3.53 3.69
OpEx 2,596 2,635 2,821 2,368 2,527 2,538 2,697 2,995 3,036 3,394 3,261 2,948 2,738 2,576 2,523 2,684 2,900 2,893 2,927 2,968
Change (%) 1.51 7.04 -16.05 6.71 0.44 6.26 11.05 1.39 11.79 -3.94 -9.58 -7.13 -5.91 -2.05 6.35 8.05 -0.24 1.19 1.39
% of Revenue 69.60 68.72 69.52 76.99 82.22 86.75 87.05 84.04 82.84 80.61 80.86 84.16 86.60 93.45 93.86 92.17 90.94 86.96 87.67 86.75
Operating Income 1,134 1,200 1,237 708 546 388 401 569 629 816 772 555 424 181 165 228 289 434 412 453
Change (%) 5.78 3.12 -42.78 -22.81 -29.04 3.48 41.75 10.63 29.76 -5.47 -28.10 -23.63 -57.36 -8.59 38.06 26.70 50.11 -5.10 10.16
% of Revenue 30.40 31.28 30.48 23.01 17.78 13.25 12.95 15.96 17.16 19.39 19.14 15.84 13.40 6.55 6.14 7.83 9.06 13.04 12.33 13.25
Interest Expense -13 -18 -16 -13 -20 -17 -15 -22 -37 -35 -49 -57 -27 -32 -29 -30 -28 -26 -22 -19
Change (%) 33.71 -12.17 -17.11 54.02 -13.25 -10.02 42.18 70.36 -5.28 36.97 18.27 -53.59 19.50 -7.75 2.18 -5.43 -10.14 -12.73 -16.44
% of Revenue -0.35 -0.46 -0.38 -0.42 -0.64 -0.59 -0.50 -0.62 -1.02 -0.84 -1.20 -1.64 -0.84 -1.16 -1.09 -1.03 -0.89 -0.77 -0.67 -0.54
Net Income 1,067 1,158 1,183 684 528 431 473 484 299 407 377 274 360 110 76 140 225 369 361 382
Change (%) 8.48 2.17 -42.19 -22.84 -18.25 9.60 2.31 -38.17 36.07 -7.33 -27.38 31.63 -69.36 -30.80 83.73 60.42 63.74 -2.00 5.60
% of Revenue 28.61 30.19 29.15 22.23 17.17 14.74 15.26 13.57 8.16 9.66 9.35 7.81 11.40 4.00 2.84 4.82 7.06 11.08 10.82 11.15

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista